T-Cell Engagers Will Beat CART Cell Therapies in RRMM

被引：0
|
作者：
Usmani, Saad [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2022年 / 22卷
关键词：
CT;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S108 / S108
页数：1
相关论文
共 50 条
  • [1] Bispecific T-Cell Engagers and Chimeric Antigen Receptor T-Cell Therapies in Glioblastoma: An Update
    Alsajjan, Roa
    Mason, Warren P.
    CURRENT ONCOLOGY, 2023, 30 (09) : 8501 - 8549
  • [2] Combination therapies for the optimisation of Bispecific T-cell Engagers in cancer treatment
    Zhu, Winston M.
    Middleton, Mark R.
    IMMUNOTHERAPY ADVANCES, 2023, 3 (01):
  • [3] T-Cell Engagers - Modern Immune-Based Therapies for Multiple Myeloma
    Mailankody, Sham
    Landgren, Ola
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (06): : 558 - 561
  • [4] Bispecific T-Cell Engagers Therapies in Solid Tumors: Focusing on Prostate Cancer
    Simao, Diana C.
    Zarrabi, Kevin K.
    Mendes, Jose L.
    Luz, Ricardo
    Garcia, Jorge A.
    Kelly, William K.
    Barata, Pedro C.
    CANCERS, 2023, 15 (05)
  • [5] Advancing Multiple Myeloma Immunotherapy: A Review of Chimeric Antigen Receptor T-Cell and Bispecific T-Cell Engagers Cell Therapies in Revolutionizing Treatment
    Navab, Rahul
    Futela, Pragyat
    Kumari, Verkha
    Valecha, Jayesh
    Gupta, Ramansh Bandhu
    Jain, Rohit
    IRANIAN JOURNAL OF MEDICAL SCIENCES, 2025, 50 (01) : 1 - 10
  • [6] Associations of T-cell fitness prior to B-cell maturation antigen (BCMA)-targeted chimeric antigen receptor T-cell (CART) and bispecific T-cell engager (BiTE) therapies and efficacy/toxicity in relapsed/refractory multiple myeloma (RRMM)
    Theprungsirikul, Poy
    Yu, Mansen
    Rall, Kerri
    Matthews, Martin
    Neparidze, Natalia
    Parker, Terri L.
    Browning, Sabrina
    Anderson, Tara
    Stevens, Erica
    Foss, Francine M.
    Gowda, Lohith
    Pillai, Manoj
    Isufi, Iris
    Seropian, Stuart
    Mirza, Sayeef
    Bar, Noffar
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [7] T-cell therapies for T-cell lymphoma
    Toner, Keri
    Bollard, Catherine M.
    Dave, Hema
    CYTOTHERAPY, 2019, 21 (09) : 935 - 942
  • [8] Bispecific T-cell engagers for cancer immunotherapy
    Huehls, Amelia M.
    Coupet, Tiffany A.
    Sentman, Charles L.
    IMMUNOLOGY AND CELL BIOLOGY, 2015, 93 (03): : 290 - 296
  • [9] Combination of Virotherapy and T-cell Therapy: Arming Oncolytic Virus with T-cell Engagers
    Song, Xiao-Tong
    DISCOVERY MEDICINE, 2013, 16 (90) : 261 - 266
  • [10] Disrupting B and T-cell collaboration in autoimmune disease: T-cell engagers versus CAR T-cell therapy?
    Shah, Kavina
    Leandro, Maria
    Cragg, Mark
    Kollert, Florian
    Schuler, Franz
    Klein, Christian
    Reddy, Venkat
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2024, 217 (01): : 15 - 30
12345